drugset

drugset / Trial / NCT00366730

Study of Nitazoxanide in the Treatment of Amebiasis in Children

NCT00366730 ↗

Phase 3 Completed 50 enrolled Romark Laboratories L.C.

RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of nitazoxanide suspension in treating diarrhea caused by Entamoeba histolytica in children.

Timeline

Start: 2004-02
Primary completion: —
Completion: 2005-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Nitazoxanide	Other / unclassified	—	—

Indications